Newly-merged Evolva signs discovery deal with Roche

Monday 4 January 2010

The newly merged Swiss company, Evolva Holding SA, has signed a deal with the Roche group to discover compounds with activity on targets in oncology and anti-infectives. The financial terms were not disclosed.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Switzerland